“It was a pleasure to attend this nice meeting, I was particularly impressed by the quality of discussions warmest regards”
Prof. Gérald Simonneau, MD
Professor of Pulmonolgy
Head, Department of Pulmonary Disease and Intensive Care,
Hospital Antoine Beclere-Clamart - University Paris XI.
“SAPH2018 provided a carefully constructed blend of talks and speakers who managed both to provide depth and breadth across the whole spectrum of pulmonary hypertension. Importantly, organization and scheduling were well executed and the facilities were outstanding. The program ran to time as well as providing ample opportunity for discussion. There were lively and entertaining debates on hot topics which were delivered in good spirit, but with debaters nonetheless deliberately taking polarized views. If SAPH2018 is anything to go by, SAPH2019 promises to be even better!”
Luke Howard, MA, MB, BChir, DPhil, FRCP
Consultant Respiratory Physician
Imperial College Healthcare, NHS Trust, London
London, United Kingdom
“It was a great pleasure to attend this year’s SAPH2018 meeting in Dubai. Congratulations on a fantastic event! The scientific sessions were of very high standard and the entire organization of the meeting was outstanding. Every year it gets better and better. You should be enormously proud of your achievements.
SAPH is a shining example of what can be achieved through collaboration, sharing and the hard work and engagement of many individuals. We are so very proud to be working with you and hope that, with your help, we will be able to support other regions in their endeavor to further the understanding of PH/PVD and follow the ‘SAPH Example’.
Finally, thank you so much for your most generous hospitality.”
Thanks for making me a part of this important academic event in the Global Chest Disease Calendar.”
PVRI (Pulmonary Vascular Research Institute)
Canterbury, United Kingdom
“I have attended now several SAPH meetings including the first one in Dubai back in 2006. The meeting has tremendously matured scientifically over the years and it is a great honor for us at the PVRI to be part of it. You have also accomplished a very important job regionally and are an example for what needs to be done in other regions of the world.
The scientific content, breadth of lectures, interaction with the audience were all exceptionally good.
Again congratulations on a great job. The SAPH has clearly become an entity to reckon with internationally!”
Paul Hassoun, MD
Director, Pulmonary Hypertension Program,
Professor of Medicine,
Division of Pulmonary and Critical Care Medicine,
Department of Medicine
The Johns Hopkins University, Baltimore
Baltimore, Maryland, USA
“SAPH 2018 had brought together a distinguished group of scientists and experts in the field of pulmonary hypertension from across the world to share experiences and debate the latest yet to be published guidelines for pulmonary hypertension.
Hussam Sakkijha, MD
Chairman, Scientific Committee
Consultant, Pulmonary, Critical Care and Sleep Medicine
King Fahad Medical City, Riyadh
Riyadh, Saudi Arabia